Matthew C. Perez, MD

Surgical Oncologist, Department of Cutaneous Oncology
Moffitt Cancer Center
Tampa, Florida, United States

Presentation(s):

• P41. Predictors of manufacturing success after tumor tissue procurement for tumor infiltrating lymphocyte cell therapy

  Thursday, March 5, 2026
  2:25 PM - 2:32 PM MST

• P47. Outcomes of Percutaneous Hepatic Perfusion with Melphalan for Metastatic Uveal Melanoma to the Liver: Post FDA Approval Real World Data

  Thursday, March 5, 2026
  3:07 PM - 3:14 PM MST